TCTR20220418005已完成不适用
Clinical Profile of Hepatoblastoma
Department of Surgical Gastroenterology0 个研究点目标入组 23 人开始时间: 2022年4月18日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 23
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 2 Months 至 60 Months（—）
- 性别
- All
入选标准
- •patients who were diagnosed with hepatoblastoma
排除标准
- •Other pathological causes of liver mass in children.
研究者
相似试验
尚未招募
不适用
Clinical study of liver cancerCTRI/2023/02/049609Kasturba Medical College, Manipal
已完成
3 期
Polyethylene Glycol (PEG) Versus Lactulose in the treatment of Hepatic EncephalopathyCTRI/2017/07/008995Institute of Medical Sciences57
已完成
不适用
Prognosis of patient with hepatocellular carcinoma in chronic hepaitits C.Hepatitis CJPRN-C000000227Ikeda Municipal Hospital100
已完成
3 期
Treatment of Children with All Stage of Hepatoblastoma with Temsirolimus(IND#122782, NSC#683864) Added to High Risk Stratum TreatmentHepatoblastomaJPRN-UMIN000019840Children's Oncology Group3
已完成
不适用
Development of the hepato-biliary-pancreatic tumor-specific imaging technique on targeting amino acid transporterhepatocellular carcinoma,biliary tract cancer,pancreatic cancerJPRN-UMIN000025110Osaka City University60